Impar Servicos Hospitalares S/A

Rio de Janeiro 22061-080

0 studies enrolling now · 2 studies all time

What they study most

Advanced or Metastatic Non-small Cell Lung Cancer, Atrial Fibrillation

Studies at this site

• A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer — Running, not enrolling
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling